Grant: Discovery Grants Program - Individual
University of Western Ontario
$28,000.00
Tumor cell transendothelial migration
EF 2006-07
Résumé
The Development of multi-cellular organisms and the maintenance of tissue function require cells interacting with one another. Much is known about how interactions between cells of the same type are regulated and functionally integrated. However, during embryonic development when cells rearrange and migrate to give rise to different organs and in the adult organism cells of diverse origins and with different functions often interact. Very little is known about this kind of communication between different cell types. To address this issue we developed a cell culture model where we can examine interactions of tumor cells with the endothelium, a cell layer that lines blood vessels. In this proposal we explore whether tumor cells exchange molecular signals with endothelial cells passing through membrane channels at cell-cell contacts. Can these signals activate the machinery for migratory behavior? Do tumor cells release factors that activate signals in the endothelium to assist in tumor cell migration by generating passageways? We will genetically engineer tumor cells to enable them to make membrane channels. We will test whether this ability changes their behavior when interacting with the endothelium and explore if this communication activates known regulatory signals that drive cell migration. We will expose endothelium with tumor-secreted factors and examine the tightness of endothelial cell-cell contacts. By genetically manipulating regulatory signals that control endothelial tightness we will explore if tumor cell invasion is affected. These experiments will establish a link between tumor cell communication with endothelium and the mechanisms that drive migratory behavior and will show how this communication aids or prevents tumor cell migration. We anticipate discovering fundamental mechanisms that regulate cellular behavior through specific interactions of cells of different type and function. The knowledge gained will help our understanding of how organisms develop and how the functions of different tissues are integrated. Support for this proposal will aid in the training of highly qualified cell biologist with anticipated careers in the academic sector, the health science field, and the pharmaceutical industry.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
326809-2006
Name nom
Sandig, Martin
Department département
Anatomy and Cell Biology
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5102
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Inter-cellular communication
Research subject fr
Communication inter-cellulaire
Partie
1
Nb partie
5
Application title
Tumor cell transendothelial migration
Keyword
NA
Application summary
The Development of multi-cellular organisms and the maintenance of tissue function require cells interacting with one another. Much is known about how interactions between cells of the same type are regulated and functionally integrated. However, during embryonic development when cells rearrange and migrate to give rise to different organs and in the adult organism cells of diverse origins and with different functions often interact. Very little is known about this kind of communication between different cell types. To address this issue we developed a cell culture model where we can examine interactions of tumor cells with the endothelium, a cell layer that lines blood vessels. In this proposal we explore whether tumor cells exchange molecular signals with endothelial cells passing through membrane channels at cell-cell contacts. Can these signals activate the machinery for migratory behavior? Do tumor cells release factors that activate signals in the endothelium to assist in tumor cell migration by generating passageways? We will genetically engineer tumor cells to enable them to make membrane channels. We will test whether this ability changes their behavior when interacting with the endothelium and explore if this communication activates known regulatory signals that drive cell migration. We will expose endothelium with tumor-secreted factors and examine the tightness of endothelial cell-cell contacts. By genetically manipulating regulatory signals that control endothelial tightness we will explore if tumor cell invasion is affected. These experiments will establish a link between tumor cell communication with endothelium and the mechanisms that drive migratory behavior and will show how this communication aids or prevents tumor cell migration. We anticipate discovering fundamental mechanisms that regulate cellular behavior through specific interactions of cells of different type and function. The knowledge gained will help our understanding of how organisms develop and how the functions of different tissues are integrated. Support for this proposal will aid in the training of highly qualified cell biologist with anticipated careers in the academic sector, the health science field, and the pharmaceutical industry.